Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment

Blood

Volumn 94, Issue 12, 1999, Pages 4195-4201

  Egeler, R Maarten ^a   Favara, Blaise E ^b   Van Meurs, Marjan ^b   Laman, Jon D ^b   Claassen, Eric ^b  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ARTICLE; BIOPSY TECHNIQUE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTIOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; LANGERHANS CELLS; MALE; T-LYMPHOCYTES;

EID: 0032778769     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Broadbent V, Egeler RM, Nesbit ME Jr: Langerhans cell histiocytosis - Clinical and epidemiological aspects. Br J Cancer 70:S11, 1994 (suppl XXIII)
2. Egeler RM, D'Angio GJ: Medical progress: Langerhans cell histiocytosis. J Pediatr 127:1, 1995
3. Writing Group of the Histiocyte Society (Chu T, D'Angio GJ, Favara B, Ladisch S, Nesbit M, Pritchard J): Histiocytosis syndromes in children. Lancet 1:208, 1987
4. Schmitz L, Favara BE: Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12:221, 1998
5. De Graaf JH, Tamminga RYJ, Dam-Miering A, Kamps WA, Timens W: The presence of cytokines in Langerhans cell histiocytosis. J Pathol 180:400, 1996
6. Kannourakis G, Abbas A: The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer 70:S37, 1994 (suppl XXIII)
7. Claassen E, Gerritse K, Laman JD, Boersma WJ: New immunoenzyme-cytochemical stainings for the in situ detection of epitope specificity and isotype of antibody forming B cells in experimental and natural (auto) immune responses in animals and man. J Immunol Methods 150:207, 1992
8. Hoefakker S, Boersma WJ, Claassen E: Detection of human cytokines in situ using antibody and probe based methods. J Immunol Methods 185:149, 1995
9. Nezelof C, Basset F: Langerhans cell histiocytosis research; past, present and future. Hematol Oncol Clin North Am 12:385, 1998
10. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG: Langerhans cell histiocytosis (histiocytosis X) - A clonal proliferate disease. N Engl J Med 331:154, 1994
11. Mellman I, Turley SJ, Steinman RM: Antigen processing for amateurs and professionals. Trends Cell Biol 8:231, 1998
12. Steinman RM, Pack M, Inaba K: Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev 156:25, 1997
13. Laman JD, Claassen E, Noelle RJ: Functions of CD40 and its ligand, gp39 (CD40L). Crit Rev Immunol 16:59, 1996
14. Hart DNJ: Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 90:3245, 1997
15. + hematopoietic progenitor cells. Blood 75:2292, 1990
16. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263, 1994
17. Heufler C, Koch F, Schuler G: Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700, 1988
18. Ralfkiaer E, Stein H, Ralfkiaer N, Hou-Jensen K, Mason DY: Normal and neoplastic Langerhans cells: Phenotypic comparison with other types of macrophages. Adv Exp Med Biol 186:1009, 1985
19. Kaplan G, Walsh G, Guido LS, Meyn P, Burkhardt RA, Abalos RM, Barker J, Frindt PA, Fajardo TT, Celona R: Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 175:1717, 1992
20. Larregina A, Morelli A, Kolkowski E, Fainboim L: Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short-term culture. Immunol 87:317, 1996
21. Steiner G, Tsachler E, Tani M, Malek TR, Shevvach EM, Holter W, Knapp W, Wolff K, Stingl G: Interleukin-2 receptors on cultured murine epidermal Langerhans cells. J Immunol 137:155, 1986
22. Davies EG, Levinsky RJ, Butler M: Thymic hormone therapy for histiocytosis X. N Engl J Med 309:493, 1983
23. Lahey ME, Heyn R, Ladisch S, Leikin S, Neerhout R, Newton W, Shore N, Smith B, Wara W, Hammond D: Hypergammaglobulinemia in histiocytosis X. J Pediatr 107:572, 1985
24. Mahmoud HH, Wang WC, Murphy SB: Cyclosporin therapy for advanced Langerhans cell histiocytosis. Blood 77:721, 1991
25. Komp DM: Langerhans cell histiocytosis. N Engl J Med 316:747, 1987
26. 2 in culture. J Clin Invest 77:326, 1986
27. Emile JF, Peuchmaur M, Fraitag S, Bodemer C, Brousse N: Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans cell histiocytosis. Histopathology 23:327, 1993
28. De Graaf JH, Tamminga RYJ, Kamps WA, Timens W: Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. Am J Pathol 147:1161, 1995
29. Emile JF, Fraitag S, Andry P, Leborgne M, Lellouch-Tubiana A, Brousse N: Expression of GM-CSF receptor by Langerhans cell histiocytosis cells. Virchows Arch 427:125, 1995
30. Emile JF, Tartour E, Brugieres L, Donadieu J, Le Deist F, Charnoz I, Fischer A, Fridman WH, Brousse N: Detection of GM-CSF in the sera of children with Langerhans cell histiocytosis. Pediatr Allergy Immunol 5:162, 1994
31. Schultz C, Klouche M, Friedrichsdorf S, Richter N, Kroehnert B, Bucsky P: Langerhans cell histiocytosis in children: Does soluble interleukin-2-receptor correlate with both disease extent and activity? Med Pediatr Oncol 31:61, 1998
32. Caux C, Dezutter-Dambuyant D, Schmitt D, Banchereau J: GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
33. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G: Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur J Immunol 25:1943, 1995
34. Ludewig B, Henn V, Schröder JM, Graf D, Kroczek RA: Induction, regulation, and function of soluble TRAP (CD40-ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. Eur J Immunol 26:3137, 1996
35. Koch F, Heufler C, Kampgen E, Schneeweiss D, Bock G, Schuler G: Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med 171:159, 1990
36. Reid CD, Stackpoole A, Meager A, Tikerpae J: Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 149:2681, 1992
37. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286, 1994
38. Saven A, Figueroa ML, Piro LD, Rosenblatt JD: 2-Chlorodeoxy-adenosine to treat refractory histiocytosis X (letter). N Engl J Med 329:734, 1993
39. Stine KC, Saylors RL, Williams LL, Becton DL: 2-Chlorodeoxy-adenosine (2-Cda) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 29:288, 1997
40. Carson DA, Wasson DB, Taetle R, Yu A: Specific toxicity of 2-chlorodeoxy-adenosine toward resting and proliferating human lymphocytes. Blood 62:737, 1983
41. Saven A, Carrera CJ, Carson DA, Beutler E, Piro LD: 2-Chlorodeoxyadenosine: An active agent in the treatment of cutaneous T-cell lymphoma. Blood 80:587, 1992
42. Carrera CJ, Terai C, Lotz M, Curd JG, Piro LD, Beutler E, Carson DA: Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. J Clin Invest 86:1480, 1990